Standing Behind Our Suspension Ferris Announces Two New Programs To Support Landscapers, Homeowners And Dealers

Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Ferris is introducing a new industry-leading, 10-year suspension warranty with a 24-hour suspension parts guarantee, making this the longest suspension warranty in the industry. Worry-free 10-year suspension warranty: Proof that it's built to lastFerris was the first to engineer full suspension for riding mowers and we remain […]

Vanguard to Showcase Advanced Battery Technology and Enhanced Engine Lineup at Equip Exposition 2025

Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Vanguard will showcase its powerful lineup of commercial gas engines and battery solutions at the Equip Exposition in Louisville, Kentucky, from October 22-24. As a trusted power expert, for original equipment manufacturers (OEMs), Vanguard will display its latest innovations as part of the Briggs & Stratton exhibit

Vanguard Battery Technology Powers FIRSTGREEN Industries’ Innovative MiniZ Electric Loader

Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Briggs & Stratton is showcasing the power and durability of its Vanguard(TM) 48V 7kWh(1) Commercial Battery (Fi7.0) through a real-world application with its partner FIRSTGREEN Industries, an innovator in electric heavy equipment. The result is the MiniZ, a powerful and compact electric tracked loader designed for demanding

Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy

(NasdaqGM:CLYM), WELLESLEY HILLS, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has strengthened its leadership team with the appointments of Adam Villa as Senior Vice President, Technical Operations, and Ashley Jones as Senior Vice President, People & Workforce

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress

(NASDAQ:EXEL),(NASDAQ:LEGN),(NASDAQ:AKRO), DUBLIN and OXFORD, United Kingdom and PHILADELPHIA, Oct. 21, 2025 (GLOBE NEWSWIRE) — SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced the appointments of Charles “Chip” R. Romp and Tom J. Heyman to its Board of Directors. These appointments further align SynOx's business

Billy Goat Unveils Next-Generation Hurricane(TM) Stand-On Blowers: The Z3002 and X3002

Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Billy Goat is pleased to announce the launch of the new Z3002 and X3002 Hurricane(TM) Stand-On Blowers. These models are built upon the robust performance of the prior 3001 series, incorporating significant new and carried-over upgrades focused on increasing durability, enhancing operator comfort, and improving ease of

Verde AgriTech Confirms Ionic Adsorption with High-Value Magnet Rare Earths; Leachate MREO up to ~300 mg/kg with No Uranium Contaminant

(TSX:NPK),(OTC US:VNPKF),(Other OTC:VNPKF), SINGAPORE, Oct. 21, 2025 (GLOBE NEWSWIRE) — Verde AgriTech Ltd. (TSX: NPK | OTCQX: VNPKF) (“Verde” or the “Company“), is pleased to report ionic-adsorption behaviour confirmed across multiple trenches at the Minas Americas Global Alliance Project (“Minas Americas” or the “Project”) in Minas Gerais, Brazil. Ammonium-sulfate leach tests returned primary leach solutions

Recurrent Energy Closes $825 Million in Project Financing for Arizona Energy Projects

Recurrent Energy's latest solar and energy storage projects support Arizona Public Service's record power needs Recurrent Energy, a subsidiary of Canadian Solar Inc.(“Canadian Solar”) (NASDAQ: CSIQ) and a global developer, owner, and operator of solar and energy storage assets, today announced it has closed $825 million in construction financing and tax equity for its Desert

Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis

(NasdaqGM:SION), SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that

Hengrui Pharma and Kailera Therapeutics Announce Phase 3 HRS9531 Obesity Data Presentation at ObesityWeek(R) 2025

SHANGHAI and WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Hengrui Pharma (Hengrui), a global pharmaceutical company focused on scientific and technological innovation, and Kailera Therapeutics, Inc. (Kailera), a clinical-stage biopharmaceutical company focused on advancing a differentiated, late-stage portfolio of next-generation therapies for the treatment of obesity, today announced an oral presentation at ObesityWeek(R) 2025,

Scroll to Top